Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1992-02-24
1995-04-11
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
424 177, 424 9, 514 64, 544229, 544238, 562 7, 562 20, 549333, 556436, 568 6, 568328, 568381, A61K 4100, A61K 4300, C07F 502, C07F 504
Patent
active
054055989
ABSTRACT:
Compounds of formula I and II ##STR1## in which B contains a carboranyl group and one of R.sub.3 and R.sub.4 is a carboranyl group or a boronic acid or ester are useful sensitizing agents for boron neutron capture therapy.
REFERENCES:
patent: H505 (1988-08-01), Slatkin et al.
patent: 4247474 (1981-01-01), Breslow
patent: 4959356 (1990-09-01), Miura et al.
patent: 5021572 (1991-06-01), Gabel
patent: 5066479 (1991-11-01), Hawthorne
patent: 5130302 (1992-07-01), Spielvogel et al.
Yamamoto et al, J. Chem. Soc., Chem. Commun., pp. 157-158 (1992).
Schinazi et al, J. Org. Chem., vol. 50, pp. 841-847, (1985).
Liotta Dennis C.
Schinazi Raymond F.
LandOfFree
Sensitizing agents for use in boron neutron capture therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sensitizing agents for use in boron neutron capture therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sensitizing agents for use in boron neutron capture therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1536815